This case involved prescription of testosterone replacement therapy in a patient with prostate cancer.
A patient was prescribed testosterone replacement therapy by his doctor following complaints of chronic fatigue. Unfortunately, the hormone that is required to be measured prior to this type of treatment to ensure the patient does not have prostate cancer (PSA) was never carried out. Additionally, the patient was never warned about the risk of prostate cancer growth associated with this type of therapy. After several years, the patient was diagnosed with stage 4 prostate cancer, which essentially was a death sentence. The Cleveland medical malpractice lawyers at Tittle & Perlmuter were able to negotiate a seven-figure settlement on behalf of the patient.